Navigation Links
IVCC launches groundbreaking insecticide projects with Bayer and Syngenta
Date:9/11/2007

The Innovative Vector Control Consortium (IVCC) has embarked upon the next phase of its initial five year strategy with the launch of the first tranche of funded projects to develop new public health mosquito control products. The three projects, with partners Bayer CropScience and Syngenta, complement established IVCC projects developing improved mosquito control information systems.

The Syngenta project, in association with the London School of Hygiene and Tropical Medicine (LSHTM), will seek to develop a new long lasting Indoor Residual Spray (IRS) formulation to help control malaria and other diseases transmitted by mosquito vectors.

The first Bayer CropScience project, in partnership with the Medical Research Council, South Africa, the Liverpool School of Tropical Medicine (LSTM) and LSHTM, is also aimed at developing a long lasting IRS formulation for malaria and other vector borne diseases. The second Bayer project includes LSTM and the University of Liverpool as partners to modify current active insecticide ingredients to overcome pesticide resistance.

Commenting on the projects, IVCC Chief Executive Janet Hemingway said: The launch of these projects is the next stage in the development of IVCC as an organisation playing a key role in the development of new public health insecticides and better vector control information systems.

Several other IVCC-supported projects are already making good progress in the development of tools which will enable pesticides to be deployed more effectively and efficiently.

We are now looking at funding a further tranche of projects, including the development of entirely new active ingredients for pesticides that will greatly improve vector control in disease endemic countries.

Prof. Dr. Friedrich Berschauer, Chairman of the Board of Management of Bayer CropScience AG said: This partnership is a clear sign for us that our expertise and our long-term commitment to fight malaria by offering effective products in vector control has been acknowledged. We are very proud to work with the IVCC on finding a sustainable solution in the combat of one of the worlds most devastating diseases.

Kris Sirchio, Global Head of Professional Products at Syngenta said: We are delighted to be a lead partner with the IVCC and to have reached this important milestone. Syngenta is a world-leading innovator in insecticide technology and we are committed to delivering products that improve health and quality of life. Combining our capabilities with those of IVCC will help accelerate the development of new vector management programs which will benefit communities where the need is greatest.


'/>"/>

Contact: Alan Hughes
a.p.hughes@liv.ac.uk
Liverpol School of Tropical Medicine
Source:Eurekalert

Related medicine news :

1. Glaxo launches pills to help smokers quit in 7-12 weeks
2. Ajanta Launches Worlds First Once-A-Day Nimesulide Oral Formulation
3. Dr Reddy’s Laboratories launches Hyalosy
4. Serum Institute Launches New Tetanus-Diphtheria Vaccine
5. Scottish Health Minister Launches Organ Donor Plan
6. GlaxoSmithKline launches diabetes and cancer drugs
7. Ranbaxy Launches Once-a-day Inhaler For Asthma Patients
8. Pfizer Launches Viagra For Lung Disease In UK
9. PM Launches Healthcare Foundation For India
10. African Union Launches A Programme On Acceleration of HIV Prevention
11. Yale School of Medicine Launches Telemonitoring Of Heart Failure Symptoms
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2017)... ... February 26, 2017 , ... NuevaCare, a leading home care agency ... Belmont, and Palo Alto, is proud to announce an important upgrade to its geographic ... for home care close to home, and by having city-specific pages, NuevaCare is answering ...
(Date:2/26/2017)... ... February 26, 2017 , ... IndustryArchive.Org . is announcing a ... Marketing. B2B Sellers will now only pay for B.A.N.T. quality sales leads based on ... IndustryArchive.Org, said, “Given the new reality that B2B buyers are controlling the sales process ...
(Date:2/26/2017)... ... February 26, 2017 , ... ODH, Inc.™ announced today ... 27-28 at the Sheraton Pentagon City Hotel in Arlington, VA. ODH’s director of medical ... behavioral health analytics to improve Medicaid population health management. , ODH will also have ...
(Date:2/26/2017)... ... February 26, 2017 , ... ... (PD) in persons with a specific LRRK2 mutation, according to a study released ... studies have provided evidence of a link between pesticides and incidence of sporadic ...
(Date:2/24/2017)... ... February 24, 2017 , ... ... TaskMate Go. Core benefits and advantages built into the home office sit stand ... look and feel. Ability to gain the benefits embedded in the TaskMate Go ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... 2017 Research and Markets has announced the ... - 2016" report to their offering. ... The latest research Urinary Incontinence Drugs ... benchmarks in the global Urinary Incontinence market. The research answers ... key drugs marketed for Urinary Incontinence and their clinical attributes? How ...
(Date:2/23/2017)... Feb. 23, 2017  Cogentix Medical, Inc. (NASDAQ: CGNT), ... innovative proprietary products for the urology market, will release ... ended December 31, 2016 before the market open on ... will host a conference call and webcast to discuss ... 9, 2017 at 11:00 a.m. Eastern Time (10:00 a.m. ...
(Date:2/23/2017)... 2017 Research and Markets has announced the ... - 2016" report to their offering. ... The latest research Oesophageal Cancer Drugs ... benchmarks in the global Oesophageal Cancer market. The research ... the key drugs marketed for Oesophageal Cancer and their clinical attributes? ...
Breaking Medicine Technology: